PRINCETON, N.J., July 11, 2023 CytoSorbents Corporation , a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification via its.
/PRNewswire/ CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in intensive care and cardiac surgery using.
CytoSorbents Receives Full FDA Approval of Investigational Device Exemption (IDE) for U S STAR-T Trial on Ticagrelor Removal During Cardiothoracic Surgery prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.